The health care system in the United States is at a turning point. We are e
xperiencing a shift in focus from structure and process to outcomes, and fr
om specific clinical outcomes to generic outcomes. It is no longer sufficie
nt to document where and how care is delivered and what clinical indicators
were changed through various interventions. Rather, payers, employers, and
patients themselves demand evidence that the health care system produces p
atients who feel better, can do more, and are confident about their health.
These concepts, collectively referred to as Health-Related Quality of Life
(HQL), are an important aspect of the natural history of liver diseases an
d an important means of assessing the results of therapeutic interventions.